Press release
Epigenetics Market Study Explores Industry Growth Toward $35 Billion
The epigenetics market is capturing increasing attention as advances in medical science and technology unfold. Driven by innovations in precision medicine and expanding pharmaceutical research, this sector is set for impressive growth. Below is an overview of the market size projections, key players, emerging trends, and segmentation that shape the future of epigenetics.Projected Expansion of the Epigenetics Market by 2030
The epigenetics market is anticipated to experience remarkable growth in the coming years, reaching a valuation of $35.01 billion by 2030. This corresponds to a strong compound annual growth rate (CAGR) of 22.3%. The rapid expansion is fueled by several factors such as rising investments in precision medicine, increasing adoption of epigenetic-based therapies, and the broadening scope of personalized oncology treatments. Additionally, the growing use of AI-driven genomic analytics and enhanced collaboration between pharmaceutical companies and research organizations are critical drivers. Key trends highlighted for the forecast period include a surge in epigenetic biomarker utilization in cancer care, widespread acceptance of high-throughput epigenetic analysis technologies, increased demand for DNA methylation assays, advancements in epigenetics-focused drug discovery, and stronger integration of bioinformatics solutions.
Download a free sample of the epigenetics market report:
https://www.thebusinessresearchcompany.com/sample.aspx?id=7070&type=smp&utm_source=OpenPR&utm_medium=Paid&utm_campaign=Jul_PR
Current Industry Leaders in the Epigenetics Market
Several prominent companies lead the epigenetics field, including Illumina Inc., Thermo Fisher Scientific, Merck Millipore, Active Motif, Abcam PLC, Qiagen NV, Diagenode SA, CellCentric Ltd., Chroma Medicine Inc., Constellation Pharmaceuticals Inc., Domainex Ltd., Eisai Co. Ltd., Epigen Biosciences Inc., EpigenDx Inc., Epigenomics AG, Epizyme Inc., Gilead Sciences Inc., GlaxoSmithKline plc, Janssen Pharmaceuticals Inc., MDxHealth SA, Novartis AG, OncoDNA SA, Oryzon Genomics S.A., Pfizer Inc., Syndax Pharmaceuticals Inc., and Valirx plc. A notable development occurred in July 2023 when New Day Diagnostics, a US-based molecular and epigenetic diagnostics provider, acquired nearly all assets of Epigenomics AG, a German company specializing in DNA methylation-based in vitro diagnostic cancer tests. This acquisition aims to enhance New Day Diagnostics' precision epigenetic testing capabilities and expand its cancer biomarker portfolio.
Growing Emphasis on AI-Driven Analytics in Epigenetics
Leading companies in the epigenetics market are increasingly prioritizing the incorporation of artificial intelligence (AI) into their analytical processes. AI-driven analytics involves leveraging AI technologies to automatically analyze vast datasets, providing deeper insights and faster outcomes. In July 2023, FOXO Technologies, a US-based firm, introduced Bioinformatics Services designed to transform epigenetic data analysis. Their platform offers tailored, advanced computational tools to support clients in academia, healthcare, and pharmaceutical research. By utilizing innovative bioinformatics software, FOXO aims to improve the speed and precision of data processing and interpretation, thereby accelerating scientific discoveries and advancing understanding of complex diseases.
View the full epigenetics market report:
https://www.thebusinessresearchcompany.com/report/epigenetics-global-market-report?utm_source=OpenPR&utm_medium=Paid&utm_campaign=Jul_PR
Distinct Segmentation of the Epigenetics Market
The epigenetics market is segmented comprehensively to cover a wide array of products, technologies, applications, and end-users. The product categories include reagents, enzymes, instruments, and kits. Technologies embraced within the market encompass DNA methylation, histone methylation, histone acetylation, large noncoding RNA, microRNA modifications, and chromatin structure studies. Applications span oncology, metabolic disorders, developmental biology, immunology, cardiovascular conditions, and other fields. End-users consist of academic and research institutions, pharmaceutical and biotechnology companies, contract research organizations, and other relevant entities. Further sub-segments under reagents include DNA methylation reagents, histone modification reagents, RNA modification reagents, and enzymes. Enzyme categories include DNA methyltransferases, histone acetyltransferases, and histone deacetylases. Instrumentation features sequencers, PCR machines, microarray platforms, and mass spectrometers. Kits cover DNA methylation kits, chromatin immunoprecipitation (ChIP) kits, RNA-Seq kits, and bisulfite conversion kits.
This detailed breakdown highlights the diverse and specialized nature of the epigenetics market, setting a foundation for continued innovation and growth in the years ahead.
What's new in our 2026 market reports:
• Market attractiveness scoring and analysis
• Total addressable market (TAM) analysis
• Company scoring matrix graphics and tables
• Excel dashboards
• Market hotspots infographics
• Key technologies and future trends
• Updated graphics and tables
Reach out to us:
The Business Research Company: https://www.thebusinessresearchcompany.com/,
Americas +1 310-496-7795,
Europe +44 7882 955267,
Asia & Others +44 7882 955267 & +91 8897263534,
Email us at info@tbrc.info.
Follow Us On:
LinkedIn: https://in.linkedin.com/company/the-business-research-company,
Twitter: https://twitter.com/tbrc_info,
YouTube: https://www.youtube.com/channel/UC24_fI0rV8cR5DxlCpgmyFQ
Learn More About The Business Research Company
With over 17500+ reports from 27 industries covering 60+ geographies, The Business Research Company has built a reputation for offering comprehensive, data-rich research and insights. Armed with 1,500,000 datasets, the optimistic contribution of in-depth secondary research, and unique insights from industry leaders, you can get the information you need to stay ahead.Our flagship product, the Global Market Model (GMM), is a premier market intelligence platform delivering comprehensive and updated forecasts to support informed decision-making.
This release was published on openPR.
Permanent link to this press release:
Copy
Please set a link in the press area of your homepage to this press release on openPR. openPR disclaims liability for any content contained in this release.
You can edit or delete your press release Epigenetics Market Study Explores Industry Growth Toward $35 Billion here
News-ID: 4570531 • Views: …
More Releases from The Business Research Company
Fracture Fixation Products Market Demonstrates Long-Term Growth Potential At 7.3 …
The fracture fixation products market is set for significant expansion in the coming years, driven by a range of medical and technological advancements. With increasing injury rates and evolving orthopedic practices, this sector is poised to reach new heights by 2030. Below, we explore the market's growth projections, key players, emerging trends, segmentation, and regional outlook.
Forecasted Growth Trajectory of the Fracture Fixation Products Market
The fracture fixation products market…
Foreign Body Removal Market Outlook Signals Expansion To $2.88 Billion Through 2 …
The foreign body removal market is poised for significant expansion as advanced medical technologies and evolving healthcare needs drive innovation and demand. With increasing emphasis on minimally invasive procedures and outpatient care, this sector is set to experience robust growth over the coming years. Below, we explore the market's valuation outlook, leading players, emerging trends, and detailed segment information.
Expected Market Size and Growth Trajectory of the Foreign Body Removal Market…
Foot And Ankle Devices Market Report 2026 Market Outlook Supported By A Forecast …
The foot and ankle devices industry is on track for significant growth in the coming years, driven by technological innovation and increasing demand for tailored orthopedic care. As the market evolves, advancements in surgical techniques and materials are expected to open new avenues for treatment and rehabilitation. Let's explore the current market size, key players, emerging trends, and the segmentation of this dynamic sector.
Projected Market Growth and Size of the…
Folding-Wheel Personal Mobility Robot Market Insights Highlight Segment Expansio …
The folding-wheel personal mobility robot market is poised to experience remarkable growth in the coming years, driven by advancing technologies and increasing demand for versatile mobility options. As technology evolves and more applications emerge, this sector is set to transform personal transportation, especially for users seeking convenience and enhanced mobility.
Projected Expansion of the Folding-Wheel Personal Mobility Robot Market by 2030
The market for folding-wheel personal mobility robots is anticipated…
More Releases for Epigen
Metastatic Triple Negative Breast Cancer Pipeline Analysis 2024: FDA Approvals a …
(Las Vegas, Nevada, United States) As per DelveInsight's assessment, globally, Metastatic Triple Negative Breast Cancer pipeline constitutes 10+ key companies continuously working towards developing 12+ Metastatic Triple Negative Breast Cancer treatment therapies, analysis of Clinical Trials, Therapies, Mechanism of Action, Route of Administration, and Developments analyzes DelveInsight.
"Metastatic Triple Negative Breast Cancer Pipeline Insight, 2024" report by DelveInsight outlines comprehensive insights into the present clinical development scenario and…
HDAC Inhibitor Clinical Trials 2024 (Updated): EMA, PDMA, FDA Approvals, Clinica …
(Albany, United States) As per DelveInsight's assessment, globally, HDAC Inhibitor pipeline constitutes 50+ key companies continuously working towards developing 50+ HDAC Inhibitor treatment therapies, analysis of Clinical Trials, Therapies, Mechanism of Action, Route of Administration, and Developments analyzes DelveInsight.
"HDAC Inhibitor Pipeline Insight, 2024" report by DelveInsight outlines comprehensive insights into the present clinical development scenario and growth prospects across the HDAC Inhibitor Market.
The HDAC Inhibitor Pipeline report embraces in-depth commercial…
HDAC Inhibitor Clinical Trials Analysis 2024 (Updated): FDA Approvals, Pipeline, …
(Albany, United States) As per DelveInsight's assessment, globally, HDAC Inhibitor pipeline constitutes 50+ key companies continuously working towards developing 50+ HDAC Inhibitor treatment therapies, analysis of Clinical Trials, Therapies, Mechanism of Action, Route of Administration, and Developments analyzes DelveInsight.
"HDAC Inhibitor Pipeline Insight, 2024" report by DelveInsight outlines comprehensive insights into the present clinical development scenario and growth prospects across the HDAC Inhibitor Market.
The HDAC Inhibitor Pipeline report embraces in-depth commercial…
HDAC Inhibitor Pipeline Assessment 2024 (Updated): FDA, EMA, PDMA Approvals, Cli …
(Las Vegas, Nevada, United States) As per DelveInsight's assessment, globally, HDAC Inhibitor pipeline constitutes 50+ key companies continuously working towards developing 50+ HDAC Inhibitor treatment therapies, analysis of Clinical Trials, Therapies, Mechanism of Action, Route of Administration, and Developments analyzes DelveInsight.
"HDAC Inhibitor Pipeline Insight, 2024" report by DelveInsight outlines comprehensive insights into the present clinical development scenario and growth prospects across the HDAC Inhibitor Market.
The HDAC Inhibitor Pipeline report embraces…
DelveInsight's 2023 Update on HDAC Inhibitor Pipeline Drugs: FDA Approvals, Clin …
(Las Vegas, Nevada, United States) As per DelveInsight's assessment, globally, HDAC Inhibitor pipeline constitutes 50+ key companies continuously working towards developing 50+ HDAC Inhibitor treatment therapies, analysis of Clinical Trials, Therapies, Mechanism of Action, Route of Administration, and Developments analyzes DelveInsight.
"HDAC Inhibitor Pipeline Insight, 2023" report by DelveInsight outlines comprehensive insights into the present clinical development scenario and growth prospects across the HDAC Inhibitor Market.
The HDAC Inhibitor Pipeline report embraces…
Lysophosphatidic Acid Receptor Market Extensive Demand, New Development, and Res …
The latest Release from "Stratagem Market Insights" is titled "Lysophosphatidic Acid Receptor Market Research Report 2022-2030", This Market report offers qualitative and quantitative insights as well as a thorough examination of the market size and expansion rate of all potential market segments. The report has been put together using primary and secondary research methodologies, which offer an exact and detailed understanding of the market. The research report on the …
